Comparative Benchmarking
In the context of the broader market, TLSI competes directly with industry leaders such as QTRX and DCTH. With a market capitalization of $299.66M, it holds a significant position in the sector. When comparing efficiency, TLSI's gross margin of N/A stands against QTRX's 45.69% and DCTH's 85.48%. Such benchmarking helps identify whether TriSalus Life Sciences Inc is trading at a premium or discount relative to its financial performance.
